Cargando…
The Roles of Genetic Polymorphisms and Human Immunodeficiency Virus Infection in Lipid Metabolism
Dyslipidemia has been frequently observed among individuals infected with human immunodeficiency virus type 1 (HIV-1), and factors related to HIV-1, the host, and antiretroviral therapy (ART) are involved in this phenomenon. This study reviews the roles of genetic polymorphisms, HIV-1 infection, and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844249/ https://www.ncbi.nlm.nih.gov/pubmed/24319689 http://dx.doi.org/10.1155/2013/836790 |
_version_ | 1782293144809766912 |
---|---|
author | de Almeida, Elaine Regina Delicato Reiche, Edna Maria Vissoci Kallaur, Ana Paula Flauzino, Tamires Watanabe, Maria Angelica Ehara |
author_facet | de Almeida, Elaine Regina Delicato Reiche, Edna Maria Vissoci Kallaur, Ana Paula Flauzino, Tamires Watanabe, Maria Angelica Ehara |
author_sort | de Almeida, Elaine Regina Delicato |
collection | PubMed |
description | Dyslipidemia has been frequently observed among individuals infected with human immunodeficiency virus type 1 (HIV-1), and factors related to HIV-1, the host, and antiretroviral therapy (ART) are involved in this phenomenon. This study reviews the roles of genetic polymorphisms, HIV-1 infection, and highly active antiretroviral therapy (HAART) in lipid metabolism. Lipid abnormalities can vary according to the HAART regimen, such as those with protease inhibitors (PIs). However, genetic factors may also be involved in dyslipidemia because not all patients receiving the same HAART regimen and with comparable demographic, virological, and immunological characteristics develop variations in the lipid profile. Polymorphisms in a large number of genes are involved in the synthesis of structural proteins, and enzymes related to lipid metabolism account for variations in the lipid profile of each individual. As some genetic polymorphisms may cause dyslipidemia, these allele variants should be investigated in HIV-1-infected patients to identify individuals with an increased risk of developing dyslipidemia during treatment with HAART, particularly during therapy with PIs. This knowledge may guide individualized treatment decisions and lead to the development of new therapeutic targets for the treatment of dyslipidemia in these patients. |
format | Online Article Text |
id | pubmed-3844249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38442492013-12-08 The Roles of Genetic Polymorphisms and Human Immunodeficiency Virus Infection in Lipid Metabolism de Almeida, Elaine Regina Delicato Reiche, Edna Maria Vissoci Kallaur, Ana Paula Flauzino, Tamires Watanabe, Maria Angelica Ehara Biomed Res Int Review Article Dyslipidemia has been frequently observed among individuals infected with human immunodeficiency virus type 1 (HIV-1), and factors related to HIV-1, the host, and antiretroviral therapy (ART) are involved in this phenomenon. This study reviews the roles of genetic polymorphisms, HIV-1 infection, and highly active antiretroviral therapy (HAART) in lipid metabolism. Lipid abnormalities can vary according to the HAART regimen, such as those with protease inhibitors (PIs). However, genetic factors may also be involved in dyslipidemia because not all patients receiving the same HAART regimen and with comparable demographic, virological, and immunological characteristics develop variations in the lipid profile. Polymorphisms in a large number of genes are involved in the synthesis of structural proteins, and enzymes related to lipid metabolism account for variations in the lipid profile of each individual. As some genetic polymorphisms may cause dyslipidemia, these allele variants should be investigated in HIV-1-infected patients to identify individuals with an increased risk of developing dyslipidemia during treatment with HAART, particularly during therapy with PIs. This knowledge may guide individualized treatment decisions and lead to the development of new therapeutic targets for the treatment of dyslipidemia in these patients. Hindawi Publishing Corporation 2013 2013-11-12 /pmc/articles/PMC3844249/ /pubmed/24319689 http://dx.doi.org/10.1155/2013/836790 Text en Copyright © 2013 Elaine Regina Delicato de Almeida et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article de Almeida, Elaine Regina Delicato Reiche, Edna Maria Vissoci Kallaur, Ana Paula Flauzino, Tamires Watanabe, Maria Angelica Ehara The Roles of Genetic Polymorphisms and Human Immunodeficiency Virus Infection in Lipid Metabolism |
title | The Roles of Genetic Polymorphisms and Human Immunodeficiency Virus Infection in Lipid Metabolism |
title_full | The Roles of Genetic Polymorphisms and Human Immunodeficiency Virus Infection in Lipid Metabolism |
title_fullStr | The Roles of Genetic Polymorphisms and Human Immunodeficiency Virus Infection in Lipid Metabolism |
title_full_unstemmed | The Roles of Genetic Polymorphisms and Human Immunodeficiency Virus Infection in Lipid Metabolism |
title_short | The Roles of Genetic Polymorphisms and Human Immunodeficiency Virus Infection in Lipid Metabolism |
title_sort | roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844249/ https://www.ncbi.nlm.nih.gov/pubmed/24319689 http://dx.doi.org/10.1155/2013/836790 |
work_keys_str_mv | AT dealmeidaelainereginadelicato therolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism AT reicheednamariavissoci therolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism AT kallauranapaula therolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism AT flauzinotamires therolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism AT watanabemariaangelicaehara therolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism AT dealmeidaelainereginadelicato rolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism AT reicheednamariavissoci rolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism AT kallauranapaula rolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism AT flauzinotamires rolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism AT watanabemariaangelicaehara rolesofgeneticpolymorphismsandhumanimmunodeficiencyvirusinfectioninlipidmetabolism |